Ascendis Pharma AS (A71) — Capital Reinvestment Ratio
Latest as of December 2025:
0.05x
Ascendis Pharma AS (A71) has a Capital Reinvestment Ratio of 0.05x as of December 2025, meaning it reinvests 0% of its operating cash flow (€73.40 Million) in capital expenditures (€3.39 Million). See A71 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.05x
Capex / Operating Cash Flow
Operating Cash Flow
€73.40 Million
EUR
Capital Expenditures
€3.39 Million
EUR
Data as of
Dec 2025
Most recent filing
Ascendis Pharma AS Capital Reinvestment Ratio (2025–2025)
This chart tracks Ascendis Pharma AS's Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for Ascendis Pharma AS (2025–2025)
Year-by-year Capital Reinvestment Ratio for Ascendis Pharma AS from 2025 to 2025. For live market cap and broader valuation context, see market cap of Ascendis Pharma AS.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.16x | €53.90 Million | €8.48 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow